Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease

被引:0
|
作者
R A Sweet
B Devlin
B G Pollock
D L Sukonick
K B Kastango
S-A Bacanu
K V Chowdari
S T DeKosky
R E Ferrell
机构
[1] Graduate School of Public Health,Division of Geriatrics and Neuropsychiatry, Department of Psychiatry
[2] University of Pittsburgh,Department of Neurology
[3] School of Medicine,Department of Human Genetics
[4] Graduate School of Public Health,undefined
[5] University of Pittsburgh,undefined
[6] Graduate School of Public Health,undefined
[7] University of Pittsburgh,undefined
来源
Molecular Psychiatry | 2005年 / 10卷
关键词
alzheimer; alzheimer disease; psychosis; geriatric; genetic;
D O I
暂无
中图分类号
学科分类号
摘要
Psychotic symptoms in subjects with Alzheimer disease (AD with psychosis, AD+P) define a phenotype characterized by greater cognitive burden than in AD without psychosis. We have proposed that genes of small effect may contribute to the risk for expression of psychosis in multiple disorders, including AD. Recently, sex-differential association of a three-locus haplotype, including a G → A transition at codon 108/158 of catechol-O-methyltransferase (COMT) resulting in a Val → Met substitution, has been reported to confer an increased risk for schizophrenia. The main objective of the study was to determine if COMT genetic variation is associated with risk of psychosis in AD, and included a case–control study of 373 individuals diagnosed with AD with, or without, psychosis. All subjects were characterized for alleles at the three loci associated with schizophrenia, RS737865, COMT G → A 108/158 (RS4680), and RS165599, and for a C/T transition adjacent to an estrogen response element (ERE6) in the COMT P2 promoter region. Both single locus and haplotype tests of association were conducted. Logit models were used to examine independent and interacting effects of alleles at the associated loci. All analyses were stratified by sex. In female subjects, RS4680 demonstrated a modest association with AD+P; RS737865 demonstrated a trend towards an association. There was a highly significant association of AD+P with the four-locus haplotype, which resulted from additive effects of alleles at RS4680 and ERE6 (or RS737865, as this locus was in almost absolute linkage disequilibrium (LD) with ERE6). In male subjects, no single locus test was significant, but there remained a strong association between AD+P and the four-locus haplotype. This association appeared to result from interaction of the ERE6/RS737865, RS4680, and RS165599 loci. Genetic variation in COMT is associated with AD+P, and thus appears to contribute to psychosis risk across disorders. Sex-differential associations of COMT with psychosis may result from variation at, or in LD with, ERE6. Examination of variation at ERE6 in subjects with schizophrenia, and further examination of the independent and additive effects of variations in COMT on gene expression, is warranted.
引用
收藏
页码:1026 / 1036
页数:10
相关论文
共 50 条
  • [1] Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease
    Sweet, RA
    Devlin, B
    Pollock, BG
    Sukonick, DL
    Kastango, KB
    Bacanu, SA
    Chowdari, KV
    DeKosky, ST
    Ferrell, RE
    [J]. MOLECULAR PSYCHIATRY, 2005, 10 (11) : 1026 - 1036
  • [2] Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer Disease
    Borroni, B
    Agosti, C
    Archetti, S
    Costanzi, C
    Bonomi, S
    Ghianda, D
    Lenzi, GL
    Caimi, L
    Di Luca, M
    Padovani, A
    [J]. NEUROSCIENCE LETTERS, 2004, 370 (2-3) : 127 - 129
  • [3] Catechol-O-methyltransferase haplotypes and risk for psychosis in AD
    Wilkosz, Patricia
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 61 (08) : 144S - 144S
  • [4] Catechol-O-methyltransferase, Cognition and Alzheimer's Disease
    Perkovic, Matea Nikolac
    Strac, Dubravka Svob
    Tudor, Lucija
    Konjevod, Marcela
    Erjavec, Gordana Nedic
    Pivac, Nela
    [J]. CURRENT ALZHEIMER RESEARCH, 2018, 15 (05) : 408 - 419
  • [5] Catechol-O-methyltransferase and the clinical features of psychosis
    McClay, J. L.
    Fanous, A.
    van den Oord, E. J. C. G.
    Webb, B. T.
    Walsh, D.
    O'Neill, F. A.
    Kendler, K. S.
    Chen, X.
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (08) : 935 - 938
  • [6] Catechol-O-Methyltransferase Genetic Variant Associated with the Risk of Alzheimer's Disease in a Brazilian Population
    Pereira, Patricia Araujo
    Romano-Silva, Marco Aurelio
    Camargos Bicalho, Maria Aparecida
    de Moraes, Edgar Nunes
    Malloy-Diniz, Leandro
    Garcia Santos Pimenta, Guilherme Jose
    Mello, Marina Pena
    Reis Sguizzato Bozzi, Isadora Cristine
    de Marco, Luiz Armando
    Nicolato, Rodrigo
    Miranda, Debora Marques
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2012, 34 (02) : 90 - 95
  • [7] CATECHOL-O-METHYLTRANSFERASE
    FLOHE, L
    [J]. INTERNATIONAL PHARMACOPSYCHIATRY, 1974, 9 (01): : 52 - 60
  • [8] Catechol-O-Methyltransferase and Alzheimer's Disease: A Review of Biological and Genetic Findings
    Serretti, Alessandro
    Olgiati, Paolo
    [J]. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (03) : 299 - 305
  • [9] Catechol-O-Methyltransferase and Cardiovascular Disease: MESA
    Hall, Kathryn T.
    Battinelli, Elisabeth
    Chasman, Daniel I.
    Ridker, Paul M.
    Psaty, Bruce M.
    Rotter, Jerome I.
    Kaptchuk, Ted J.
    Tracy, Russell P.
    Wassel, Christina L.
    Mukamal, Kenneth J.
    [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2019, 8 (24):
  • [10] Catechol-O-methyltransferase gene haplotypes in Mexican and Spanish patients with fibromyalgia
    Gilberto Vargas-Alarcón
    José-Manuel Fragoso
    David Cruz-Robles
    Angélica Vargas
    Alfonso Vargas
    José-Ignacio Lao-Villadóniga
    Ferrán García-Fructuoso
    Manuel Ramos-Kuri
    Fernando Hernández
    Rashidi Springall
    Rafael Bojalil
    Maite Vallejo
    Manuel Martínez-Lavín
    [J]. Arthritis Research & Therapy, 9